GRACE MCDONALD: Open Payments
NPI 1528846425 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,166 in 99 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $2,334 · 2025 $2,166
Food & beverage: $2,166
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 24 | $526 |
| Amgen Inc. | 17 | $386 |
| GENZYME CORPORATION | 7 | $218 |
| ABBVIE INC. | 11 | $211 |
| Incyte Corporation | 11 | $209 |
| Novartis Pharmaceuticals Corporation | 8 | $183 |
| Galderma Laboratories, L.P. | 5 | $113 |
| Janssen Biotech, Inc. | 4 | $82 |
| Arcutis Biotherapeutics, Inc. | 3 | $63 |
| LEO Pharma Inc. | 3 | $57 |
Products named: Bimzelx, Otezla, DUPIXENT, OPZELURA, COSENTYX, SKYRIZI, RINVOQ, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
